ClinicalTrials.Veeva

Menu

Thrombolysis With Intra-arterial Urokinase

Chang Gung Medical Foundation logo

Chang Gung Medical Foundation

Status

Completed

Conditions

Arterial Occlusion Mesenteric Artery Superior

Treatments

Procedure: intra-arterial urokinase thrombolysis

Study type

Observational

Funder types

Other

Identifiers

NCT04688879
202000381B0

Details and patient eligibility

About

Patients with acute superior mesenteric artery (SMA) occlusion were included in this study. The clinical presentation and effect of the recanalization of the SMA was analyzed on follow-up angiography.

Full description

Thirteen patients with acute SMA occlusion who underwent intra-arterial urokinase thrombolysis between 2008 and 2020 were retrospectively evaluated.

Clinically, the abdominal pain and the effect of the SMA on angiography will be compared in response and non-response groups.

Enrollment

13 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of SMA occlusion

Exclusion criteria

  • shock in the triage screening
  • peritonitis
    1. intramural gas, mesenteric or portal venous gas on contrast-enhanced abdominal CT

Trial design

13 participants in 1 patient group

According to the degree of occlusion, 13 patients were divided into complete and incomplete groups.
Description:
Seven patients were complete occlusion and 6 patients were incomplete occlusion and all underwent thrombolysis with intra-arterial urokinase and the outcome was analysed..
Treatment:
Procedure: intra-arterial urokinase thrombolysis

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems